Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
A hepatitis B titer test measures anti-HBs (hepatitis B surface antibody) levels in your blood to show whether you are protected from the virus, along with markers like HBsAg and anti-HBc that reveal past or current infection. A level of 10 mIU/mL or higher generally indicates immunity, while a result under 10 mIU/mL is considered low or "non-immune," which may mean your vaccine response has waned, you never fully responded to the series, or you need revaccination and further testing. There are several important factors to consider, including your age, immune status, occupation, and which specific markers came back positive or negative, so see below for the complete answer before drawing conclusions about your results.
Because a low titer can mean very different things depending on your health history, vaccination timeline, and any symptoms you may be experiencing, it helps to get clarity on what your body is telling you right now. Take a free, instant, online symptom check to better understand your situation and get guidance on the right next steps, including whether to ask your doctor about a booster dose or additional hepatitis B testing.
Last reviewed for medical accuracy: 10/01/2026
A hepatitis B titer test measures the level of antibodies your immune system has developed against the hepatitis B virus (HBV). It’s most often used to:
Below is an overview of what this test shows, how to interpret your results, and what a low antibody level might mean for you.
What exactly is being measured?
How the test is done
Why anti-HBs and not antigens?
Your report will generally fall into one of three categories:
Protective (Immune)
Non-responder / Susceptible
High titer
If your anti-HBs level is below 10 mIU/mL, it suggests one of the following:
No adequate response to vaccination
• About 5–10% of healthy adults do not develop enough antibodies after a standard vaccine series.
• Common in older adults, smokers, people with obesity, or those with certain chronic illnesses.
Waning immunity over time
• Antibody levels can decline over years, though immune memory often persists.
• In healthy individuals, a drop below 10 mIU/mL does not always mean full loss of protection.
Laboratory variability
• Slight differences in testing methods can influence results around the 10 mIU/mL cutoff.
• A repeat test may be advised if your level is borderline.
Booster dose or revaccination
Assess for factors affecting response
Consider specialized protocols
Monitor occasionally if you remain at risk
A low hepatitis B titer is usually not a medical emergency, but it does mean you may need additional vaccine doses or evaluation of your immune status. Always:
If you experience any serious symptoms—such as sudden jaundice, abdominal pain, persistent nausea, or unexplained fatigue—seek medical care promptly or call emergency services. You might also consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to help determine if you should see a provider right away.
Maintaining protective immunity against hepatitis B is straightforward once you understand your titer results. With timely follow-up and the right vaccination strategy, you can ensure you stay protected.
(References)
* Moraczewska Z, Madaliński K, Holland PV. Simultaneous presence in serum of HBsAg and anti-HBs of different specificities. Intervirology. 1978;9(3):189-92. doi: 10.1159/000148936. PMID: 412814.
* Laure F, Zagury D, Saimot AG, Gallo RC, Hahn BH, Brechot C. Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex. Science. 1985 Aug 9;229(4713):561-3. doi: 10.1126/science.2410981. PMID: 2410981.
* Lambert-Gardini S, Colarossi GG, Sergiacomi U, Gozzo L, Nuzzolo L. Reduction and disappearance of anomalous fluorescence patterns by means of absorption of HIV and EBV positive sera to guinea pig kidney and calf erythrocytes: a preliminary study. Boll Ist Sieroter Milan. 1988;67(5-6):351-6. PMID: 2856487.
* Nechaev VV, Mukomolov SL, Shliakhtenko LI, Mikhaĭlov MI, Zubov SV. [Patients with chronic viral hepatitis as sources of infection]. Zh Mikrobiol Epidemiol Immunobiol. 1988 Apr;(4):32-6. PMID: 2970739.
* Bonino F, Recchia S, Ponzetto A, Filippone B, Palla M, Zanetti AR, Ferroni P. A solid-phase enzyme immunoassay (EIA) for detection of HBeAg and anti-HBe. J Immunol Methods. 1980;33(2):195-200. doi: 10.1016/s0022-1759(80)80009-3. PMID: 6768806.
* Burrell CJ. Serological markers of hepatitis B infection. Clin Gastroenterol. 1980 Jan;9(1):47-63. PMID: 6994952.
* Yan BM, Lee SS. Acute coinfection with hepatitis B and hepatitis C viruses. Can J Gastroenterol. 2005 Dec;19(12):729-30. doi: 10.1155/2005/514813. PMID: 16341313.
* Towell V, Cowie B. Hepatitis B serology. Aust Fam Physician. 2012 Apr;41(4):212-4. PMID: 22472681.
* Travers CP, Connell J, Thornton L, Keane E, Knowles S, Murphy JF. Follow up of infants born to women with hepatitis B in the National Maternity Hospital. Ir Med J. 2015 May;108(5):147-9. PMID: 26062242.
* Cadet MJ. Screening for Hepatitis B: Serology Markers Interpretation. Workplace Health Saf. 2018 Oct;66(10):512. doi: 10.1177/2165079918794707. Epub 2018 Aug 23. PMID: 30136615.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.